Testosterone and Aging: What You Need to Know

This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before making health decisions based on this content.

By TriCountyUrology Editorial Team | Last verified: August 2026

What Testosterone Is: Definition and Natural Role in Aging

Testosterone is the primary male sex hormone and belongs to a class of compounds called androgens. It is produced primarily in the testicles, and to a much smaller extent in the adrenal glands. In adult men, testosterone levels are about seven to eight times higher than in adult women, with daily production roughly 20 times greater in men due to differences in metabolism.

Testosterone plays critical roles throughout the body: it drives muscle and bone development, supports sexual function and libido, influences mood and cognition, regulates metabolism and energy, and protects against osteoporosis. It is essential not only for reproductive health but also for general well-being and physical vitality.

Age-related decline is natural and normal. Starting around age 30, testosterone levels in men typically decline by approximately 1% per year. By age 70, many men have testosterone levels substantially lower than in their youth. However, this decline varies widely among individuals—some men maintain relatively stable levels, while others experience steeper drops.

How Testosterone Works: Biological Pathways and Aging Effects

Testosterone exerts its effects by binding to androgen receptors found throughout the body—in muscle, bone, brain, heart, and reproductive tissues. Once bound, it triggers a cascade of molecular signals that promote anabolic (building) effects and androgenic (virilizing) effects.

Mechanisms of Action in the Aging Male Body

Testosterone in men can be metabolized in two important ways:

• Conversion to dihydrotestosterone (DHT): This more potent androgen drives male secondary sexual characteristics and influences prostate health and hair growth.
• Conversion to estradiol (E2): A form of estrogen that supports bone density, sexual function, and cardiovascular health—even in men.

With aging, the testicles produce less testosterone, and the body's ability to convert and utilize testosterone may also change. Simultaneously, sex hormone–binding globulin (SHBG) often increases with age, which binds testosterone and reduces the amount of “free” testosterone available to tissues. This combination explains why symptoms of low testosterone can emerge even when total testosterone levels appear borderline.

Effects of Low Testosterone in Aging Men

Insufficient testosterone in aging men may contribute to:

• Loss of muscle mass and strength
• Increased body fat, particularly abdominal fat
• Reduced bone density and increased fracture risk
• Erectile dysfunction and reduced libido
• Fatigue and decreased energy output
• Mood changes, including anxiety and depression
• Cognitive decline and reduced mental clarity
• Metabolic dysfunction and increased cardiovascular risk

However, these symptoms are not inevitable with aging and are not always caused by low testosterone alone.

What the Research Shows: Evidence on Testosterone and Aging

The scientific evidence on testosterone replacement therapy (TRT) in aging men is nuanced and evolving. Major studies include:

Key Clinical Trials and Findings

The Testosterone in Older Men with Mobility Limitations (TOM) Trial: This large randomized controlled trial examined testosterone gel in older men (mean age 74) with mobility limitations. Results showed modest improvements in leg strength and some functional measures, but no significant benefit for overall physical function in the majority of participants. Sexual function improved in some men.

The Testosterone Trials (TTrials): This multisite, randomized, placebo-controlled study of over 700 men (ages 65+) with baseline testosterone below 275 ng/dL found that testosterone therapy improved sexual function, bone density, and some aspects of physical performance. However, it did not prevent cognitive decline or significantly improve general quality of life in all participants.

Cardiovascular Considerations: Multiple observational studies and meta-analyses have raised concerns about increased cardiovascular events (heart attack, stroke) in some older men receiving testosterone, particularly those with pre-existing heart disease or very high doses. The relationship remains debated, and not all studies show the same risk.

Evidence Grade Summary

• Grade B (moderate evidence): Testosterone therapy improves sexual function and may increase muscle mass and bone density in men with documented low testosterone.
• Grade B-C (weaker evidence): Benefits for mood, cognition, and overall quality of life are inconsistent and modest.
• Grade B-C (weaker evidence): Effects on cardiovascular health require caution and individualized assessment; absolute risk remains uncertain.

Current consensus among urology and endocrinology organizations is that testosterone therapy may be considered in symptomatic men with documented low testosterone (typically total testosterone <300 ng/dL and free testosterone <65 pg/mL), provided cardiovascular, metabolic, and prostate risks are assessed and monitored.

Forms and Bioavailability of Testosterone Replacement

Testosterone is available in multiple forms, each with different absorption profiles and practical considerations:

Injectable Forms

• Testosterone cypionate and enanthate: Administered intramuscularly every 1–2 weeks. Produce more variable blood levels with peaks and troughs. Dosages typically range from 50–100 mg weekly.
• Testosterone undecanoate: Long-acting injectable; requires dosing every 10–14 weeks. More stable hormone levels.

Transdermal (Skin) Forms

• Gels and solutions: Applied daily to skin; absorbed variably depending on skin condition, site of application, and hydration. Common doses are 50–100 mg daily.
• Patches: Applied to skin daily; provide more stable absorption. Doses typically 2–6 mg daily.

Oral and Buccal Forms

• Oral testosterone undecanoate: Must be taken with food; variable and lower bioavailability.
• Buccal tablets: Placed between gum and cheek; absorbed through oral mucosa. Provides more consistent levels.

Subcutaneous Pellets

• Long-acting implants lasting 3–6 months. Provide steady hormone levels but require minor surgical placement.

Bioavailability matters: Transdermal forms generally provide more stable blood levels than injections, which may reduce side effects. However, some men absorb gels and patches inconsistently. Injections are less expensive but create fluctuating levels. Choice should be individualized based on preference, absorption, cost, and monitoring feasibility.

Who Should Consider Testosterone Therapy and Who Should Avoid It

Reasonable Candidates for Testosterone Replacement

• Men aged 60+ with documented low testosterone (total <300 ng/dL or free testosterone <65 pg/mL)
• Men with symptoms consistent with low testosterone (erectile dysfunction, reduced libido, fatigue, muscle loss)
• Men with normal or low prostate-specific antigen (PSA) and no active prostate cancer
• Men with stable cardiovascular status (no recent heart attack or unstable angina)
• Men willing to commit to regular monitoring (blood work every 6–12 months)

Safety and Side Effects of Testosterone Therapy

Serious Risks and Concerns

• Cardiovascular events: Some studies suggest increased risk of myocardial infarction, stroke, or heart failure, particularly in older men or those with pre-existing disease. This remains controversial and context-dependent.
• Prostate cancer promotion: Testosterone may stimulate growth of existing prostate cancer. Baseline PSA and digital rectal examination are essential before starting therapy.
• Liver toxicity: Primarily with oral forms; transdermal and injectable forms are safer for the liver.
• Infertility: Testosterone suppresses natural sperm production; men seeking fertility should discuss alternatives with their urologist.

Monitoring Requirements

Men on testosterone therapy should undergo regular assessment:

• Baseline: PSA, digital rectal exam, hematocrit, liver and kidney function
• Every 3 months initially: Serum testosterone level to ensure adequate dosing
• Every 6–12 months: PSA, hematocrit, blood pressure, cardiovascular assessment
• Annual or as needed: Clinical review of symptoms and side effects